冠狀動脈支架市場：市場規模（按細分市場）、份額、監管、報銷、程序、預測（~2033）

美國是心絞痛 (AP) 和心肌梗塞 (MI) 發生率最高的國家之一。 然而，二手資訊顯示心臟病的盛行率正在下降。 這種下降可能是由於改變生活方式和減少吸煙等預防措施所致。 在中東等地區，心臟病的盛行率正在增加。 全球心臟病的增加是由於糖尿病、高血壓、肥胖和吸煙等危險因素和合併症造成的。 此外，由於許多合併症與年齡密切相關，因此老年人口的增加預計也會導致疾病盛行率上升。 整體而言，都市化導致吸菸率上升、缺乏身體活動和不健康的生活方式。 冠狀動脈支架市場分為冠狀動脈裸金屬支架、冠狀動脈藥物洗脫支架、冠狀動脈覆膜支架及冠狀動脈生物可吸收支架。

本報告深入了解全球冠狀動脈支架市場，提供競爭格局、SWOT 分析、到 2033 年的市場預測、COVID-19 的影響、區域和國家趨勢等。Masu。

目錄

目前冠狀動脈支架市場及競爭狀況

• 對主要產業趨勢的見解
• 2015 年至 2033 年按細分市場劃分的冠狀動脈支架市場總收入及市場前景
• 按細分市場劃分的手術總數、單位數量、平均售價和市場價值的詳細數據

全球、區域與國家見解

• 冠狀動脈支架市場SWOT分析
• 冠狀動脈支架市場的競爭動態洞察與趨勢
• 各國醫療保健系統概覽
• 按國家/地區劃分的報銷政策
• 各國醫療科技的監管狀況

Abstract

Coronary Stents Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative market trends within Cardiovascular Devices therapeutic area.

The model discusses in detail the impact of COVID-19 on Coronary Stents market for the year 2020 and beyond. US has some of the highest rates of AP and MI. However, according to secondary sources the prevalence of heart disease is decreasing. This decline may be due to preventative efforts such as lifestyle changes and reduction in smoking. In regions, such as the Middle East for example the prevalence of heart disease is increasing. The global increase in heart disease can be attributed to risk factors and comorbidities such as diabetes, hypertension, obesity, and tobacco use. Moreover, as many of these comorbidities are closely tied to age, the growing elderly population will also contribute to the rising disease prevalence. Overall, urbanization has led to increased smoking rates, lack of physical activity and unhealthy lifestyle. The Coronary Stents Market is segmented into Coronary Bare Metal Stents, Coronary Drug Eluting Stents, Coronary Covered Stents, Coronary Bioabsorbable Stents.

Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed Coronary Stents market and evolving competitive landscape -

• Insightful review of the key industry trends.
• Annualized total Coronary Stents market revenue by segment and market outlooks from 2015-2033.
• Granular data on total procedures, units, average selling prices and market values by segment.

Global, Regional and Country level market specific insights -

• Qualitative market specific information is available with global trends further broken down into regional trends. In addition GlobalData analysts provide unique country specific insights on the market.
• SWOT analysis for Coronary Stents market.
• Competitive dynamics insights and trends provided Coronary Stents market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

• Country specific overview of the healthcare system.
• Country specific reimbursement policies.
• Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Boston Scientific Corp, Abbott Laboratories, Medtronic Plc, Biotronik SE & Co KG, Lepu Medical Technology (Beijing) Co Ltd, B. Braun Melsungen AG, MicroPort Scientific Corp, Sahajanand Medical Technologies Pvt Ltd, Meril Life Sciences Pvt Ltd, Translumina Therapeutics LLP, Vascular Concepts Ltd, and Others.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

• CMO executives who must have deep understanding of the Coronary stents marketplace to make strategic planning and investment decisions.
• Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
• Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

• Understand the impact of COVID-19 on Coronary Stents market.
• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
• Develop business strategies by understanding the trends shaping and driving Coronary Stents market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Coronary Stents market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Track device sales in the global and country-specific Coronary Stents market from 2015-2033.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

Table of Contents

Not Applicable

List of Tables

Not Applicable

List of Figures

Not Applicable